MARCO ISLAND, Fla. — Complete Genomics, a leading innovator in genomic sequencing, today unveiled its latest high-performance sequencing solutions at the 2025 Advances in Genome Biology and Technology (AGBT) General Meeting. The newly introduced DNBSEQ-T1+* and DNBSEQ-E25 Flash* are designed to deliver speed, flexibility, and efficiency, empowering researchers with faster, high-quality genomic data. DNBSEQ-T1+: Mid-Throughput Sequencing with Industry-Leading Speed The […]

BOSTON — Volta Labs, a leading genomics applications company, today announced its four strategic focus areas for 2025 and the expansion of the Callisto App menu to include RNA library prep and single-cell prep, and multi-sequencer capabilities. Key strategic focus areas for Volta Labs in 2025 are: Launching DNA, RNA and single-cell preps for all labs […]

Vancouver, British Columbia — Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (“Telescope Innovations“, “Telescope“, or the “Company“) is a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries. The Company is pleased to provide an update on its Self-Driving Lab (“SDL“) technology, which integrates AI, robotics, advanced […]

Cambridge, UK – Cresset, a leading provider of integrated in silico solutions for small molecule drug discovery announces the release of its Flare platform V10, bringing enhanced scientific features for both computational and medicinal chemists. The latest release includes significantly enhanced Free Energy Perturbation (FEP) calculations with the inclusion of Absolute FEP, Protein-protein docking, and Protein-Ligand […]

The QuantumScale platform enables costs of less than 1 cent per cell with workflows across an unprecedented scale SAN DIEGO — Scale Biosciences (Scale Bio™), a leader in innovative and scalable single cell analysis solutions, today announced the availability of its QuantumScale Single Cell RNA kits, a set of next-generation single cell products which can capture and […]

Commercial launch of UG 100 Solaris which includes new chemistry, software, and simplified workflows for the UG 100 sequencing platform, now with expanded applications support and integration with leading ‘omics’ technologies Over 50% increase in output to 10 to 12 billion reads per wafer and pricing reduced by 20% to $0.24 per million reads, enabling the $80 genome Increased sensitivity […]

Company expands multiomics portfolio with new roadmap technologies spanning genomics, spatial, single cell, CRISPR, and methylation, as well as a new multimodal data analysis platform Built on Illumina’s powerful sequencers, new, disruptive omics solutions surpass industry standards forquality, scale, accuracy, and replicability SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) has unveiled a series of roadmap innovations, […]

SAN DIEGO — Singular Genomics Systems, Inc., an innovator in high-throughput spatial multiomics technologies designed to advance precision medicine, today announced key development milestones for its G4X™ Spatial Sequencer at the Advances in Genome Biology and Technology (AGBT) conference in Marco Island, Florida. G4X Early Access Program Ongoing and Broader Availability on Track The G4X […]

A. Preview of timsTOF Ultra 2 system with novel Athena Ion Processor (AIP): – Improves protein group identification in single-cell proteomics (SCP) by 15%-20%, and peptide identifications in SCP by 20%-25% -Advances immunopeptidomics with 15%-20% more immunopeptide identifications B. Launch of DeutEx™ software for hydrogen-deuterium exchange (HDX-MS) analysis C. OmniScape™ 2025b: a breakthrough in top-down protein sequencing software D. Advances in […]

New single cell and spatial innovations extend 10x Genomics’ technology and performance leadership across all three platforms PLEASANTON, Calif. — At the Advances in Genome Biology and Technology (AGBT) General Meeting, 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced a series of new product innovations to solidify its position as […]